Global Ophthalmic Viscoelastic Device Market Growth 2025-2031
The global Ophthalmic Viscoelastic Device market size is predicted to grow from US$ 2723 million in 2025 to US$ 3411 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
United States market for Ophthalmic Viscoelastic Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Ophthalmic Viscoelastic Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Ophthalmic Viscoelastic Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Ophthalmic Viscoelastic Device players cover Abbott Laboratories, ZEISS Medical, Bohus BioTech, Lifecore Biomedical, Rayner, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Ophthalmic Viscoelastic Device Industry Forecast” looks at past sales and reviews total world Ophthalmic Viscoelastic Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Ophthalmic Viscoelastic Device sales for 2025 through 2031. With Ophthalmic Viscoelastic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Viscoelastic Device industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Viscoelastic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Viscoelastic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmic Viscoelastic Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Viscoelastic Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Viscoelastic Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Viscoelastic Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cohesive OVDs
Dispersive OVDs
Segmentation by Application:
Hospitals & Clinics
Ambulatory Care Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
ZEISS Medical
Bohus BioTech
Lifecore Biomedical
Rayner
SD Healthcare
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Viscoelastic Device market?
What factors are driving Ophthalmic Viscoelastic Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Viscoelastic Device market opportunities vary by end market size?
How does Ophthalmic Viscoelastic Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.